Lindbrook Capital’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
$31.2K Sell
2,096
-37
-2% -$569 ﹤0.01% 1172
2024
Q4
$31.8K Sell
2,133
-647
-23% -$10.5K ﹤0.01% 1019
2024
Q3
$53.2K Sell
2,780
-426
-13% -$8.83K ﹤0.01% 788
2024
Q2
$66.4K Buy
3,206
+1,106
+53% +$22K 0.01% 683
2024
Q1
$39.5K Buy
2,100
+262
+14% +$4.5K ﹤0.01% 881
2023
Q4
$26.5K Buy
1,838
+1,428
+348% +$19.4K ﹤0.01% 1035
2023
Q3
$7.12K Sell
410
-92
-18% -$1.92K ﹤0.01% 1585
2023
Q2
$10.4K Sell
502
-436
-46% -$9.48K ﹤0.01% 1440
2023
Q1
$22.1K Buy
938
+429
+84% +$11.5K ﹤0.01% 1022
2022
Q4
$14.2K Sell
509
-71
-12% -$1.81K ﹤0.01% 1251
2022
Q3
$14K Sell
580
-167
-22% -$5.04K ﹤0.01% 1173
2022
Q2
$25K Buy
747
+19
+3% +$665 ﹤0.01% 895
2022
Q1
$25K Buy
728
+257
+55% +$8.79K ﹤0.01% 914
2021
Q4
$14K Buy
471
+57
+14% +$1.86K ﹤0.01% 1149
2021
Q3
$14K Sell
414
-82
-17% -$2.62K ﹤0.01% 874
2021
Q2
$15K Buy
+496
New +$16.3K ﹤0.01% 896

Other funds holding OGN

Lindbrook Capital's OGN Position: Q1 2025 in Review

Lindbrook Capital reduced its Organon & Co (OGN) stake by 1.7% in Q1 2025, selling an estimated $569 and leaving 2,096 shares worth $31.2K. The position accounts for ﹤0.01% of the portfolio, ranked #1172.

Lindbrook Capital first reported a position in OGN in Q2 2021 and has held it in 16 quarters since. The position peaked at $66.4K in Q2 2024. 720 funds tracked by Wall St. Rank hold OGN as of Q1 2025.

  • Lindbrook Capital held 2,096 shares of Organon & Co worth $31.2K as of Q1 2025.
  • Lindbrook Capital sold 37 Organon & Co shares in Q1 2025, an estimated $569.
  • Organon & Co made up ﹤0.01% of Lindbrook Capital's portfolio in Q1 2025, its #1172 holding.
  • Lindbrook Capital first reported a position in Organon & Co in Q2 2021 and has held it in 16 quarters since.
  • Lindbrook Capital's Organon & Co position peaked at $66.4K in Q2 2024.
  • 720 funds tracked by Wall St. Rank held Organon & Co as of Q1 2025.

Based on Lindbrook Capital's 13F filing for Q1 2025, filed 5 May 2025.